Mondher Toumi mainly investigates Psychiatry, Cohort study, Mental health, Schizophrenia and Quality of life. His Schizophrenia study in the realm of Psychiatry interacts with subjects such as Social environment. His work in Cohort study covers topics such as Cohort which are related to areas like Atypical antipsychotic.
His Mental health research includes themes of Proportional hazards model, Epidemiology, Depression and Chronic condition. Mondher Toumi interconnects Cochrane Library and Disease, Disease burden in the investigation of issues within Schizophrenia. His studies in Quality of life integrate themes in fields like Psychosis and Cross-cultural studies.
Mondher Toumi spends much of his time researching Psychiatry, Schizophrenia, Schizophrenia, Clinical psychology and Health care. His Psychiatry research is multidisciplinary, incorporating elements of Quality of life, Cohort study and Cohort. His Health care research is mostly focused on the topic Health policy.
His main research concerns Orphan drug, Family medicine, Drug, Bioinformatics and Procurement. His study in Orphan drug is interdisciplinary in nature, drawing from both Economic growth, Disease area, Socioeconomics and Monetary economics. Mondher Toumi applies his multidisciplinary studies on Family medicine and Nice in his research.
His research brings together the fields of Finance and Drug. Mondher Toumi does research in Bioinformatics, focusing on Clinical trial specifically. In his research, he undertakes multidisciplinary study on Procurement and Public administration.
His primary scientific interests are in Systematic review, Family medicine, Risk analysis, Internal medicine and Atrial fibrillation. His studies deal with areas such as Physical therapy, Randomized controlled trial, Overactive bladder and Epidemiology as well as Systematic review. His work focuses on many connections between Family medicine and other disciplines, such as Pulmonologists, that overlap with his field of interest in Health care.
His Health care research is multidisciplinary, incorporating perspectives in One Health, Informed consent, Palliative care and Weakness. His study in the field of Meta-analysis and Vitamin K antagonist also crosses realms of Wet age-related macular degeneration and Anti vegf. The concepts of his Apixaban study are interwoven with issues in Lower risk, Cochrane Library, Myocardial infarction and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: